🟢 FUNDING
Premier Radiology Acquires Teleradiology Firm GLOBIS
Premier Radiology Services acquired teleradiology specialist GLOBIS for an undisclosed amount, continuing its acquisition spree.
Teleradiology consolidation is accelerating as scaled players pursue pricing power and operational efficiencies. Independent groups face mounting pressure to merge or risk margin compression from larger competitors.
🟢 FUNDING
Merit Medical Pays $140M for View Point Tumor Localization Devices
Merit Medical acquired View Point, a tumor tissue localization device company, for $140 million.
The deal signals growing premiums for companies that bundle imaging with interventional tools. Pure-play imaging vendors face pressure as device makers build integrated procedure platforms that combine visualization and treatment.
🔴 REGULATORY
GE HealthCare Wins FDA Clearance for Deep Learning CT Reconstruction
GE HealthCare received 510(k) clearance for True Definition DL, a deep learning CT image reconstruction technology.
The clearance lets GE command higher prices on new CT sales and drive software upgrade cycles across its installed base. Radiologists should await independent head-to-head studies before assuming diagnostic superiority over existing reconstruction methods.
🟡 COMPETITIVE
Diagnoly Launches Fetoly Fetal Ultrasound AI App on iOS
Diagnoly launched its Fetoly fetal ultrasound AI application on iOS for mobile diagnostic assistance.
Consumer-facing fetal imaging AI bypasses traditional clinical workflows, but health systems will likely avoid adoption until EHR integration, enterprise security, and liability questions are resolved. This is a market signal, not yet a clinical workflow tool.
Google News: site:auntminnie.com ultrasound · Thu, 02 Ap
Read more →
⚪ INDUSTRY
Bayer Radiology Head Ambrogio Promoted to U.S. Pharma President
Nelson Ambrogio, Bayer's global radiology division head, was named president of Bayer's U.S. pharmaceuticals division effective May 1.
Elevating imaging leadership to run U.S. pharma may signal Bayer's intent to accelerate theranostics and radiopharmaceutical strategy. Watch for shifts in contrast agent portfolios and imaging-guided therapy investments under new radiology division leadership.
🔴 REGULATORY
UltraSight Wins FDA Clearance for Cross-Platform Cardiac Echo AI
UltraSight received FDA clearance to expand its AI-guided cardiac echo platform across multiple ultrasound systems.
Vendor-agnostic clearance lets UltraSight capture revenue across the entire installed ultrasound base, threatening OEMs' proprietary AI ecosystems. This follows a week of heavy ultrasound AI activity including Samsung Medison's clearance and multiple POCUS trials launching.
Google News: POCUS point-of-care ultrasound · Wed, 01 Ap
Read more →
🩺 EDITOR’S TAKE — FOR CLINICIANS
Cross-platform AI echo guidance and mobile fetal ultrasound apps are expanding who can image and where. Watch for workflow disruption — but demand independent validation before changing protocols.
📊 EDITOR’S TAKE — FOR INVESTORS
Two acquisitions in one issue — teleradiology roll-ups and interventional imaging bolt-ons — signal consolidation appetite across imaging's fragmented middle market. Expect more deals in the $100M-plus range.
🏭 EDITOR’S TAKE — FOR INDUSTRY
UltraSight's vendor-agnostic clearance challenges OEMs' proprietary AI moats. Combined with Diagnoly's iOS launch, the trend toward software-decoupled imaging intelligence is accelerating faster than incumbents may be comfortable with.